Author/Authors :
Mouronte-Roibas, Cecilia Pulmonary Department - Hospital Alvaro Cunqueiro - Vigo Biomedical Research Institute (IBIV), Vigo, Spain , Leiro-Fernandez, Virginia Pulmonary Department - Hospital Alvaro Cunqueiro - Vigo Biomedical Research Institute (IBIV), Vigo, Spain , Botana-Rial, Maribel Pulmonary Department - Hospital Alvaro Cunqueiro - Vigo Biomedical Research Institute (IBIV), Vigo, Spain , Ramos-Hernandez, Cristina Pulmonary Department - Hospital Alvaro Cunqueiro - Vigo Biomedical Research Institute (IBIV), Vigo, Spain , Lago-Preciado, Guillermo Critical Care Department - Hospital Alvaro Cunqueiro, Vigo, Spain , Fiano-Valverde, Concepcion Pathology Department - Hospital Alvaro Cunqueiro, Vigo, Spain , Fernandez-Villar, Alberto Pulmonary Department - Hospital Alvaro Cunqueiro - Vigo Biomedical Research Institute (IBIV), Vigo, Spain
Abstract :
Mucormycosis due to Lichtheimia ramosa is an infrequent opportunistic infection that can potentially be angioinvasive when
affecting inmunocompromised hosts. We present a fatal case of mucormycosis, affecting a 56-year-old male with diabetes mellitus
and siderosis, initially admitted to our hospital due to an H1N1 infection. The subject’s clinical condition worsened and he finally
died because of a necrotizing bilateral pneumonia with disseminated mycotic thromboses due to Lichtheimia ramosa, which is
an emerging Mucoralean fungus. This is an infrequent case because of the extent to which it affected a subject without overt
immunocompromise. This case underlines the importance of an early premortem diagnosis and treatment in order to prevent
rapid progression of this disease, as well as the need of considering mucormycosis when facing subjects with multiple emboli and
fever unresponsive to usual antimicrobials.
